Wed, Apr 23, 8:06 PM (18 days ago)
SeaStar Medical Holding Corporation (ICU) filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The amendment includes updates to Part III of the Form 10-K, which was previously omitted, and corrects dates on certain exhibits. The company's financial performance, revenue, net income, and operating expenses are not detailed in this amendment, as it focuses on governance and executive matters. **Key Points:** 1. **Corporate Governance:** - The Board of Directors consists of six members, with a mix of executive and non-executive directors. - The Board has adopted a Code of Business Conduct and Ethics and charters for various committees. - The Board is divided into three classes with staggered three-year terms. 2. **Executive Compensation:** - The company provides base salaries, long-term equity incentives, and bonuses to its named executive officers. - Eric Schlorff, the CEO, received a base salary of $420,000 and equity awards. - David Green, the CFO, received a base salary of $363,702 and equity awards. - Kevin Chung, the CMO, received a base salary of $350,000 and equity awards. 3. **Director and Officer Changes:** - The amendment includes updates on the election and appointment of new directors and officers. - The company has a related person transaction policy to manage conflicts of interest. 4. **Risk Oversight:** - The Board administers risk oversight through various committees, focusing on financial risk, enterprise risk, and governance risks. 5. **Market Position:** - The company's market position changes are not detailed in this amendment, as it focuses on governance and executive matters. 6. **Financial Condition:** - The financial condition is not detailed in this amendment, as it focuses on governance and executive matters. 7. **Future Outlook:** - The future outlook is not detailed in this amendment, as it focuses on governance and executive matters. 8. **Risk Factors:** - The amendment does not detail specific risk factors but mentions the company's risk oversight processes. 9. **Strategic Overview:** - The strategic overview is not detailed in this amendment, as it focuses on governance and executive matters. 10. **Earnings Per Share (EPS):** - The EPS is not detailed in this amendment, as it focuses on governance and executive matters. The amendment does not provide detailed financial metrics but focuses on governance, executive compensation, and related matters. For a comprehensive understanding of the company's financial performance, revenue, net income, and other financial metrics, refer to the original Form 10-K filed on March 27, 2025.